New MedAware Systems Study Published in Pain Physician Journal
MedAware Systems, Inc. announced today that a major research paper entitled Sacroiliac Joint Fusion Methodology - iFuse Implant System® Compared to Screw-type Surgeries: A Systematic Review and Meta-Analysis has been published in the journal Pain Physician.Pain Physician is the official publication of the American Society of Interventional Pain Physicians (ASIPP). It is a peer-reviewed, multi-disciplinary, open access journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine.
As part of the study, over 500 research articles were collected and reviewed by the MedAware Systems team. Data from the articles were extracted and analyzed using MedAware Systems’ patent pending process in only three weeks. The results of the meta-analysis conclusively demonstrated that the iFuse Implant System, developed by SI-BONE, Inc., is far superior in fusing the sacroiliac joint across three key patient outcome measures: Pain, Disability, and Quality of Life/Patient Satisfaction.
“Approximately 15% to 30% of chronic lower back pain can be attributed to the SI joint. Recent improvements in the diagnosis of SI joint dysfunction have guided the emergence of new surgical devices and techniques. Our analysis of a large body of the medical research literature on the topic demonstrates that the iFuse Implant System results in better patient outcomes for the treatment of SI joint dysfunction due to degenerative sacroiliitis or SI joint disruption” says Founder and Chief Science Officer, Dr. Zung Vu Tran. He continues, “Interestingly, the benefits were even more pronounced in women. MedAware System’s remarkable ability to aggregate and analyze massive quantities of medical research data in a matter of weeks can result in accelerating the adoption of new medicines and medical devices, allowing more patients to benefit from these new approaches sooner.”
ABOUT MEDAWARE SYSTEMS, INC.
MedAware Systems, Inc. disrupts the health informatics industry by forever changing the way Pharma and medical device companies, physicians, payers and patients derive usable evidence from published clinical trials research. The Company’s Science of Health Informatics (SOHInfo™) is a Scientific-Data-as-a-Service (SDaaS™) that solves the problem of making the vast and chaotic body of clinical science research instantly available and indispensable for understanding the safety and efficacy of medical treatments and devices.
MedAware Systems, Inc.
3400 Industrial Ln.
Suite 1B
Broomfield, CO 80020
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New MedAware Systems Study Published in Pain Physician Journal here
News-ID: 1527248 • Views: …
More Releases from MedAware Systems, Inc.
MedAware Systems Adds Sentiment Tracking for Social Media Event Reports
MedAware Systems announced today that it has added a new Sentiment Tracking feature to its Social Media Event Monitoring application for Medical Devices. This new feature offers valuable signaling intelligence for post market surveillance and reporting for MDR and FDA filings. The feature utilizes the Company's Advanced Intelligence™ capabilities to provide deeper insight into reported events and other related posts on Social Media.
Events are identified for specific devices and…
MedAware Systems Expands Neuromodulation Device Regulatory Data Portal
MedAware Systems announced today a major expansion of Neuromodulation device data in its SOHInfo (www.sohinfo.com) customer portal. The portal is populated with reported data from registries, published literature, and social media for all registered devices for Spinal Cord Stimulation, Peripheral Nerve Stimulation, Ganglia Dorsal Root Stimulation, RF Ablation, Parkinson - Deep Brain Stimulation, Sacral Stimulation – Incontinence, and others. Global regulatory reported data is provided on all manufacturers’ products for…
MedAware Systems Launches AI-Powered Post Market Surveillance for Catheter Intro …
MedAware Systems announces that its Science of Health Informatics (SOHInfo) Post Market Surveillance Service for Catheter Introducer devices is now available.
SOHInfo monitors government regulatory adverse event databases, published literature, and social media to provide complete monitoring of the devices from all major manufacturers, including Steris Corporation, Sotera Health, Abbott, Cardinal Health, Merit Medical, Cordis Corporation, Terumo, Cook Medical, Teleflex, Medtronic, C.R. Bard, and others.
The surveillance system supports both…
MedAware Systems Adds Social Media to its Medical Device Surveillance Service
MedAware Systems’ Science of Health Informatics (SOHInfo) announces a major upgrade of its medical device surveillance service to include reporting on social media posts.
SOHInfo monitors government regulatory adverse event databases as well as relevant data from the published literature. It now includes social media surveillance to provide complete monitoring of clients’ products. The platform offers comprehensive visibility and active alerts across all three major platforms, LinkedIn, Facebook, and Twitter.…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…